Ovarian and Fallopian Tube Cancer Risk Management & Treatment

Learn about options for fallopian tube and ovarian cancer screening, prevention and treatment

Stay up to date on research and information

Sign Up for FORCE Newsletters

Fallopian Tube and Ovarian Cancer Risk

Fallopian tube, ovarian and primary peritoneal cancer are related. Any of these cancers may be referred to as ovarian cancer. Every woman is at risk for these cancers; the risk is different based on multiple factors, including:

  • age
  • presence of an inherited mutation
  • personal and family history of cancer
  • other risk factors

Inherited mutations in the genes below have been linked to increased fallopian tube and ovarian cancer risk. Note that when we use "woman" we are referring to the sex assigned at birth.

Genes Linked to Fallopian Tube and Ovarian Cancer Risk
*More research is needed to confirm a link between fallopian tube and ovarian cancer in people with PMS2 mutations.

Other Risk Factors

The following factors have been studied and may increase the risk for these cancers:

More research is needed to understand whether other factors may influence risk in people with inherited mutations.

Risk Management and Treatment

People at high risk for fallopian tube and ovarian cancer have different options for managing risk, including:

  • screening
  • medications to reduce risk
  • surgery to reduce risk

National expert guidelines for cancer risk management vary by gene mutation and level of risk. Click on the button below to learn more about these guidelines. Speak with your healthcare provider to decide on a risk-management plan and schedule that is right for you.

People diagnosed with ovarian cancer may have different treatment options based on their cancer stage and subtype as well as results from genetic testing and biomarker testing. Click on the button below to learn more about these treatment options. Speak with your healthcare provider to decide on a treatment plan that is right for you.

Last updated February 13, 2024